Skip to main
PDEX
PDEX logo

Pro-Dex (PDEX) Stock Forecast & Price Target

Pro-Dex (PDEX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Pro-Dex Inc. has demonstrated a robust financial performance, with year-over-year revenue growth of 22%, primarily fueled by increased sales from new medical device products and repair services. Additionally, the company has achieved a gross margin of 33%, reflecting effective cost management and operational efficiency. Strategic investments in private label products and winning new product contracts further position Pro-Dex for continued growth in the highly competitive medical device sector.

Bears say

The financial outlook for Pro-Dex Inc indicates a downward revision in estimates for FY25, with revenue projections decreasing from $68 million to $67 million and EPS adjusted down from $2.30 to $2.81. This adjustment signals potential challenges in achieving revenue growth and profitability targets, which may hinder investor confidence. Additionally, the company faces significant risks related to fluctuating demand for technology, competition in the market, and adverse macroeconomic factors that could further affect its financial performance.

Pro-Dex (PDEX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Pro-Dex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Pro-Dex (PDEX) Forecast

Analysts have given Pro-Dex (PDEX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Pro-Dex (PDEX) has a Strong Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Pro-Dex (PDEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.